Related Experiment Video
Updated: May 15, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Novel SLC34A3 mutation causing hereditary hypophosphataemic rickets with hypercalciuria in a Gambian family
Vickie Braithwaite1, John M Pettifor, Ann Prentice
1MRC Human Nutrition Research, Elsie Widdowson Laboratory, Cambridge, UK. vickie.braithwaite@mrc-hnr.cam.ac.uk
Insights
This study identified a novel mutation in the SLC34A3 gene causing hereditary hypophosphataemic rickets with hypercalciuria (HHRH) in Gambian siblings. This research marks the first reported cases of HHRH in Africa, highlighting a new genetic cause for the condition.
Area of Science:
- Genetics
- Pediatrics
- Biochemistry
Background:
- Hereditary rickets, specifically hereditary hypophosphataemic rickets with hypercalciuria (HHRH), is a rare genetic disorder affecting phosphate and calcium metabolism.
- Early diagnosis and genetic understanding are crucial for managing bone deformities and metabolic disturbances in affected children.
Observation:
- Three siblings in a Gambian family presented with bone deformities and biochemical evidence of HHRH, including normal vitamin D levels but abnormal phosphate and calcium excretion.
- Elevated fibroblast growth factor-23 (FGF23) levels were observed in two affected siblings.
- Genetic analysis revealed a novel homozygous mutation (S168F) in the SLC34A3 gene in affected siblings, while unaffected family members were carriers.
Findings:
- The novel S168F mutation in the SLC34A3 gene is strongly associated with HHRH in this family.
- In silico analysis predicted the S168F mutation to be damaging to the sodium-phosphate cotransporter function.
- This study establishes the first documented cases of HHRH in Africa.
Implications:
- This discovery expands the known genetic spectrum of HHRH and identifies a novel mutation.
- The findings underscore the importance of genetic testing for diagnosing rare metabolic bone diseases in diverse populations.
- This research provides a foundation for further investigation into HHRH in African populations and potential therapeutic targets.
Abstract:
Three siblings, aged 12, 4 and 2 years, presented at a Gambian clinic with bone deformities. Radiographs of knees and wrists confirmed the presence of florid rickets. The family (including 2 unaffected siblings and the mother) were investigated for hereditary rickets. The three affected siblings had biochemical features of hereditary hypophosphataemic rickets with hypercalciuria (HHRH) with normal plasma calcium and 25-hydroxyvitamin D concentrations, elevated 1,25-dihydroxyvitamin D, hypophosphataemia, hyperphosphaturia and hypercalciuria. At presentation, two of the three affected siblings had an elevated fibroblast growth factor-23 (FGF23) concentration. The mother and clinically unaffected siblings had largely normal biochemistry. Genetic analysis of the SLC34A3 gene, encoding the type IIc sodium-phosphate cotransporter, in DNA samples from the siblings and their mother was conducted. Three single nucleotide polymorphisms (SNPs) S168F, E513V and L599L were identified. E513V and L599L had been previously identified as benign polymorphisms. S168F however, is a previously unreported variant. In silico mutation evaluation predicted that the S168F mutation causes changes in the protein product which are damaging to its function. In addition, the three clinically affected siblings were homozygous in the S168F variant whereas the unaffected family members were carriers. This study describes a biochemical profile and complementary gene data consistent with a rare genetic hypophosphataemic rickets disease in a family from rural Gambia. To our knowledge, this study reports the first cases of HHRH in Africa and describes a novel causal mutation within the SLC34A3 gene.
Related Concept Videos
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Lethal Alleles
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Inborn Errors of Metabolism
Huntington Disease l: Introduction

